Heading Back North3 Sep 2021 22:03
Good to see we're heading back in the right direction especially in a turbulent market where sentiment is low, which is affecting stocks negatively. With Nasdaq listing pending, and the news this week regarding the licensing of Foralumab, sentiment has returned and the stock is now retracing. When this stock moves it absolutely flies, don't be surprised if this hits a pound before the end of next week. With low overheads, plenty of money in the bank, and now the licencing agreement with Precision BioSciences, TILS are looking very healthy indeed.
Holding very firmly.